The Associated Press - Business News on MSN15d
Civil rights activists call for a Target boycott after retailer backs away from diversity programsRead full article: Vets warn pet owners to check microchip registration after company abruptly shuts down FILE - Fake pill bottles with messages about Purdue Pharma are displayed ... activists ...
As the father of an 18-year-old girl who died from a single OxyContin pill in 2006 and as a creditor in the Purdue Pharma bankruptcy proceeding, I must voice my strong disappointment in Illinois ...
Purdue Pharma headquarters in downtown Stamford, Conn. A board of trustees – selected by “participating states in consultation with the other creditors – will determine Purdue’s future.
Bringing in top talent from the transfer portal might be the most popular way to build a successful program for some coaches, but that's not how new Purdue coach Barry Odom will operate.
INDIANAPOLIS — Conceptual renderings of Purdue’s new Academic ... District near the future Elanco global headquarters on the western edge of the White River. The initial renderings of the Academic ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...
Trey Kaufman-Renn wasn't the Purdue player in first-half foul trouble, and it allowed him to play a starring role. Braden Smith showcased his generosity in a first half that was explosive.
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to US$7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...
WEST LAFAYETTE − Purdue basketball's defense got it through a tough road trip to the Pacific Northwest. The Boilermakers saw their seven-game winning streak end because the offense couldn't ...
The Purdue and Indiana men's basketball teams faced off on Friday night with the Boilermakers coming away with an 81-76 win at Mackey Arena. There were 15 lead changes. Purdue wins No. 17 for the ...
The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results